These projects use a systems biology approach (using genomic, proteomic, and bioinformatic methods) to gain a greater insight into how metabolic function changes during life-span. This will involve conducting multiple tissue analyses on organs that are known to play a role in controlling metabolic function, such as: hypothalamus, pituitary gland, tongue, gut, pancreas, liver, adipose tissue, muscle, and gonads. Once we gain a greater insight into alterations in the metabolic/energy homeostasis super-axis during the aging process, we can then elucidate which pharmacological endocrine axes targets could be best used to enhance metabolic health. Pluripotent therapeutics that are targeted towards multiple aspects of the super-axis are likely to have much greater efficacy than those that target just one aspect in isolation.
We aim to elucidate and characterize - at a systemic level - endocrine regulation and feedback during the aging process, with special attention to euglycemic control axes and how these major energy axes may act as a master integrator for additional endocrine axes such as the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal (HPG) axes. Therefore, multiple dietary, digestive and reproductive axes can be integrated at the humoral level to form a higher order super-axis. Many of the hormones that create the complex feedback loops in this super-axis provide a multi-level connection between cognitive appreciation of food supply, energy sensation/perception and eventual energy metabolism. Using animal models of aging or metabolic pathophysiology (e.g. type 2 diabetes, metabolic syndrome, Alzheimers disease) we will use various genomic, proteomic, bioinformatic and behavioral approaches to model and predict complex endocrine feedback loops and determine which pharmacological endocrine axes targets could be best used to enhance metabolic health and improve health-span during the aging process.
|Siddiqui, Sana; Fang, Meng; Ni, Bin et al. (2012) Central role of the EGF receptor in neurometabolic aging. Int J Endocrinol 2012:739428|
|Chadwick, Wayne; Mitchell, Nicholas; Martin, Bronwen et al. (2012) Therapeutic targeting of the endoplasmic reticulum in Alzheimer's disease. Curr Alzheimer Res 9:110-9|
|Driscoll, Ira; Martin, Bronwen; An, Yang et al. (2012) Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults. PLoS One 7:e35217|
|Wu, Wells W; Wang, Guanghui; Insel, Paul A et al. (2012) Discovery- and target-based protein quantification using iTRAQ and pulsed Q collision induced dissociation (PQD). J Proteomics 75:2480-7|
|Wu, Wells W; Shen, Rong-Fong; Park, Sung-Soo et al. (2012) Precursor ion exclusion for enhanced identification of plasma biomarkers. Proteomics Clin Appl 6:304-8|
|Chadwick, Wayne; Martin, Bronwen; Chapter, Megan C et al. (2012) GIT2 acts as a potential keystone protein in functional hypothalamic networks associated with age-related phenotypic changes in rats. PLoS One 7:e36975|
|Stranahan, Alexis M; Martin, Bronwen; Maudsley, Stuart (2012) Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer's disease. Curr Alzheimer Res 9:86-92|
|Hallböök, Tove; Ji, Sunggoan; Maudsley, Stuart et al. (2012) The effects of the ketogenic diet on behavior and cognition. Epilepsy Res 100:304-9|
|Shin, Yu-Kyong; Cong, Wei-na; Cai, Huan et al. (2012) Age-related changes in mouse taste bud morphology, hormone expression, and taste responsivity. J Gerontol A Biol Sci Med Sci 67:336-44|
|Jiang, Mali; Wang, Jiawei; Fu, Jinrong et al. (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 18:153-8|
Showing the most recent 10 out of 43 publications